A phase 2 study of CMB305 and atezolizumab in NY-ESO-1+soft tissue sarcoma: Interim analysis of immunogenicity, tumor control and survival
Conference Paper
Full Text
Duke Authors
Cited Authors
- Chawla, S; Van Tine, BA; Pollack, S; Ganjoo, K; Elias, A; Riedel, RF; Attia, S; Choy, E; Okuno, S; Agulnik, M; von Mehren, M; Livingston, M; Keedy, V; Verschraegen, C; Philip, T; Bohac, C; Lu, H; Chen, M; Maki, R
Published Date
- September 1, 2017
Published In
Volume / Issue
- 28 /
Published By
Pages
- 1
Electronic International Standard Serial Number (EISSN)
- 1569-8041
International Standard Serial Number (ISSN)
- 0923-7534
Conference Name
- 42nd European-Society-for-Medical-Oncology Congress (ESMO)
Conference Location
- Madrid, SPAIN
Conference Start Date
- September 8, 2017
Conference End Date
- September 12, 2017